Cargando…

Methylation-Mediated Silencing of RBP7 Promotes Breast Cancer Progression through PPAR and PI3K/AKT Pathway

Retinoid-binding protein7 (RBP7) is a member of the cellular retinol-binding protein (CRBP) family, which is involved in the pathogenesis of breast cancer. The study aims to illustrate the prognostic value and the potential regulatory mechanisms of RBP7 expression in breast cancer. Bioinformatics an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hong, Han, Qizheng, Wang, Junhao, Zhong, Zhaoqian, Luo, Haihua, Hao, Yibin, Jiang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584705/ https://www.ncbi.nlm.nih.gov/pubmed/36276273 http://dx.doi.org/10.1155/2022/9039110

Ejemplares similares

XBP1 impacts lung adenocarcinoma progression by promoting plasma cell adaptation to the tumor microenvironment
por: Zhong, Zhaoqian, et al.
Publicado: (2022)

RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway
por: Li, Hongxia, et al.
Publicado: (2018)

Silencing of SPP1 Suppresses Progression of Tongue Cancer by Mediating the PI3K/Akt Signaling Pathway
por: Zhang, Qiaoli, et al.
Publicado: (2020)

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
por: Han, Wei, et al.
Publicado: (2022)

Nmnat1-Rbp7 Is a Conserved Fusion-Protein That Combines NAD+ Catalysis of Nmnat1 with Subcellular Localization of Rbp7
por: Chen, Hao, et al.
Publicado: (2015)

Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway
por: Hu, Wei, et al.
Publicado: (2023)

Silencing of RBP-JK promotes the differentiation of bone marrow mesenchymal stem cells into vascular endothelial cells
por: Luo, Zhengliang, et al.
Publicado: (2020)

2-Methoxyestradiol Induces Vasodilation by Stimulating NO Release via PPARγ/PI3K/Akt Pathway
por: Chen, Weiyu, et al.
Publicado: (2015)

Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
por: Yang, Dongyong, et al.
Publicado: (2021)

Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling
por: Liu, Yingge, et al.
Publicado: (2020)

Identification of the Avian RBP7 Gene as a New Adipose-Specific Gene and RBP7 Promoter-Driven GFP Expression in Adipose Tissue of Transgenic Quail
por: Ahn, Jinsoo, et al.
Publicado: (2015)

Terpenoid natural products exert neuroprotection via the PI3K/Akt pathway
por: Xu, Bingyao, et al.
Publicado: (2022)

NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling
por: Chen, Yongbing, et al.
Publicado: (2021)

Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury
por: Kitagishi, Yasuko, et al.
Publicado: (2013)

Cardamonin inhibits the progression of oesophageal cancer by inhibiting the PI3K/AKT signalling pathway
por: Wang, Zijie, et al.
Publicado: (2021)

Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach
por: Wang, Junhao, et al.
Publicado: (2021)

AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer
por: Kakumani, Pavan Kumar
Publicado: (2022)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
por: Dobbin, Zachary C., et al.
Publicado: (2013)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
por: Lisi, Lucia
Publicado: (2020)

The Silencing of Pokemon Attenuates the Proliferation of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Inhibiting the PI3K/Akt Pathway
por: Lin, Chan-Chan, et al.
Publicado: (2012)

Silencing of TRB3 Ameliorates Diabetic Tubule Interstitial Nephropathy via PI3K/AKT Signaling in Rats
por: Ma, Yali, et al.
Publicado: (2017)

Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway
por: Niu, Zehao, et al.
Publicado: (2021)

HTR7 promotes laryngeal cancer growth through PI3K/AKT pathway activation
por: Sheng, Xiaoli, et al.
Publicado: (2021)

Effects of PPARγ and RBP4 Gene Variants on Metabolic Syndrome in HIV-Infected Patients with Anti-Retroviral Therapy
por: Hung, Yuan-Pin, et al.
Publicado: (2012)

Optimised expression and purification of RBP4 and preparation of anti‐RBP4 monoclonal antibody
por: Li, Hui, et al.
Publicado: (2021)

PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
por: Lv, Shidong, et al.
Publicado: (2019)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
por: Zhu, Kunrui, et al.
Publicado: (2022)

Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
por: Ou, Yi, et al.
Publicado: (2021)

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
por: Duan, Shiyu, et al.
Publicado: (2018)

RBP-J and ITAM crosstalk
por: Zhao, Baohong
Publicado: (2015)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
por: Deng, Shuo, et al.
Publicado: (2022)

ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway
por: Cui, Yong, et al.
Publicado: (2022)

Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
por: Liu, Yanhui, et al.
Publicado: (2023)

TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
por: Huang, Dan-Hong, et al.
Publicado: (2019)

The silencing of FNDC1 inhibits the tumorigenesis of breast cancer cells via modulation of the PI3K/Akt signaling pathway
por: Yunwen, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rcnn2ufe62mah8tmagmnnmkb64